NORETHINDRONE ACETATE Drug Patent Profile
✉ Email this page to a colleague
When do Norethindrone Acetate patents expire, and when can generic versions of Norethindrone Acetate launch?
Norethindrone Acetate is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Barr, Glenmark Pharms Ltd, Novast Labs, Xiromed, Barr Labs Inc, Dr Reddys Labs Sa, and Apotex. and is included in twenty-nine NDAs.
The generic ingredient in NORETHINDRONE ACETATE is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NORETHINDRONE ACETATE?
- What are the global sales for NORETHINDRONE ACETATE?
- What is Average Wholesale Price for NORETHINDRONE ACETATE?
Summary for NORETHINDRONE ACETATE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 29 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 62 |
| Clinical Trials: | 49 |
| Patent Applications: | 4,194 |
| Drug Prices: | Drug price information for NORETHINDRONE ACETATE |
| DailyMed Link: | NORETHINDRONE ACETATE at DailyMed |
Recent Clinical Trials for NORETHINDRONE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bio Genuine (Shanghai) Biotech Co., Ltd. | Phase 3 |
| Myovant Sciences GmbH | Phase 4 |
| University of Chicago | Phase 4 |
Pharmacology for NORETHINDRONE ACETATE
| Drug Class | Progestin |
